Article Text
Letters
The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis
Statistics from Altmetric.com
Footnotes
-
Competing interests None.
-
Patient consent Obtained.
-
Ethics approval The administration of canakinumab was approved by the Scientific Council of University General Hospital of Alexandroupolis and the Greek National Organization for Medicines (EOF).
-
Provenance and peer review Not commissioned; externally peer reviewed.